We recommended an informal weight reduction diet program in all obese patients and prescribed acetazolamide (500–1,000 mg/day) and topiramate (50–100 mg/day) simultaneously for the majority of patients with ICH. The rationale for using topiramate in this condition is its broad mechanistic profile (including an inhibitor effect on carbonic anhydrase isoenzymes II and IV).